Commodore Capital LP Diversified Active

Location: New York, NY

CIK: 0001831942 · Show all filings

Period: Q4 2020 (Next →)

Filing Date: Feb 16, 2021

Total Value: $184M (100.0% shares, 0.0% debt)

Holdings (28)

CCCC C4 THERAPEUTICS INC 8.7%

Value $15.94M Shares 481,094 Est. Cost $29.00 Unrealized 0.0%

— TRILLIUM THERAPEUTICS INC 6.8%

Value $12.55M Shares 852,871 Est. Cost $14.71 Unrealized —

— CONSTELLATION PHARMCETICLS I 6.6%

Value $12.2M Shares 423,708 Est. Cost $28.80 Unrealized —

— FIVE PRIME THERAPEUTICS INC 4.9%

Value $9.049M Shares 532,000 Est. Cost $17.01 Unrealized —

— KRONOS BIO INC 4.9%

Value $8.926M Shares 298,839 Est. Cost $29.87 Unrealized —

— IVERIC BIO INC 4.8%

Value $8.805M Shares 1,274,261 Est. Cost $6.91 Unrealized —

ACRS ACLARIS THERAPEUTICS INC 4.7%

Value $8.646M Shares 1,336,275 Est. Cost $4.22 Unrealized 0.0%

COGT COGENT BIOSCIENCES INC 4.6%

Value $8.535M Shares 760,025 Est. Cost $10.99 Unrealized 0.0%

— CYMABAY THERAPEUTICS INC 4.6%

Value $8.53M Shares 1,486,107 Est. Cost $5.74 Unrealized —

PMVP PMV PHARMACEUTICALS INC 4.2%

Value $7.689M Shares 125,000 Est. Cost $39.23 Unrealized 0.0%

SNDX SYNDAX PHARMACEUTICALS INC 4.0%

Value $7.346M Shares 330,315 Est. Cost $20.74 Unrealized 0.0%

XENE XENON PHARMACEUTICALS INC 3.9%

Value $7.188M Shares 467,368 Est. Cost $11.70 Unrealized 0.0%

PTGX PROTAGONIST THERAPEUTICS INC 3.8%

Value $7.006M Shares 347,500 Est. Cost $21.52 Unrealized 0.0%

MREO MEREO BIOPHARMA GROUP PLC 3.6%

Value $6.638M Shares 1,854,278 Est. Cost $3.58 Unrealized —

CLDX CELLDEX THERAPEUTICS INC NEW 3.4%

Value $6.245M Shares 356,431 Est. Cost $18.00 Unrealized 0.0%

— VISTAGEN THERAPEUTICS INC 3.3%

Value $6.111M Shares 3,150,000 Est. Cost $1.94 Unrealized —

RLMD RELMADA THERAPEUTICS INC 3.1%

Value $5.727M Shares 178,565 Est. Cost $34.36 Unrealized 0.0%

SPRY SILVERBACK THERAPEUTICS INC 2.4%

Value $4.502M Shares 97,143 Est. Cost $33.40 Unrealized 0.0%

KURA KURA ONCOLOGY INC 2.4%

Value $4.36M Shares 133,503 Est. Cost $35.14 Unrealized 0.0%

— SURFACE ONCOLOGY INC 2.3%

Value $4.322M Shares 467,796 Est. Cost $9.24 Unrealized —

GNCAQ GENOCEA BIOSCIENCES INC 2.3%

Value $4.273M Shares 1,765,901 Est. Cost $2.28 Unrealized 0.0%

— MERSANA THERAPEUTICS INC 2.3%

Value $4.226M Shares 158,827 Est. Cost $26.61 Unrealized —

IMVT IMMUNOVANT INC 2.1%

Value $3.87M Shares 83,782 Est. Cost $46.23 Unrealized 0.0%

IVA INVENTIVA SA 1.8%

Value $3.35M Shares 231,000 Est. Cost $14.50 Unrealized —

— BCLS ACQUISITION CORP 1.5%

Value $2.785M Shares 250,000 Est. Cost $11.14 Unrealized —

— CYCLACEL PHARMACEUTICALS INC 1.1%

Value $2.067M Shares 264,690 Est. Cost $7.81 Unrealized —

— MILLENDO THERAPEUTICS INC 1.1%

Value $1.98M Shares 925,000 Est. Cost $2.14 Unrealized —

— LIFESCI ACQUISITION II CORP 0.6%

Value $1.067M Shares 100,000 Est. Cost $10.67 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CCCC	C4 THERAPEUTICS INC	481,094	$15.94M	8.7%	$29.00	0.0%	COM STK	12529R107
—	TRILLIUM THERAPEUTICS INC	852,871	$12.55M	6.8%	$14.71	—	COM NEW	89620X506
—	CONSTELLATION PHARMCETICLS I	423,708	$12.2M	6.6%	$28.80	—	COM	210373106
—	FIVE PRIME THERAPEUTICS INC	532,000	$9.049M	4.9%	$17.01	—	COM	33830X104
—	KRONOS BIO INC	298,839	$8.926M	4.9%	$29.87	—	COM	50107A104
—	IVERIC BIO INC	1,274,261	$8.805M	4.8%	$6.91	—	COM	46583P102
ACRS	ACLARIS THERAPEUTICS INC	1,336,275	$8.646M	4.7%	$4.22	0.0%	COM	00461U105
COGT	COGENT BIOSCIENCES INC	760,025	$8.535M	4.6%	$10.99	0.0%	COM	19240Q201
—	CYMABAY THERAPEUTICS INC	1,486,107	$8.53M	4.6%	$5.74	—	COM	23257D103
PMVP	PMV PHARMACEUTICALS INC	125,000	$7.689M	4.2%	$39.23	0.0%	COM	69353Y103
SNDX	SYNDAX PHARMACEUTICALS INC	330,315	$7.346M	4.0%	$20.74	0.0%	COM	87164F105
XENE	XENON PHARMACEUTICALS INC	467,368	$7.188M	3.9%	$11.70	0.0%	COM	98420N105
PTGX	PROTAGONIST THERAPEUTICS INC	347,500	$7.006M	3.8%	$21.52	0.0%	COM	74366E102
MREO	MEREO BIOPHARMA GROUP PLC	1,854,278	$6.638M	3.6%	$3.58	—	ADS	589492107
CLDX	CELLDEX THERAPEUTICS INC NEW	356,431	$6.245M	3.4%	$18.00	0.0%	COM NEW	15117B202
—	VISTAGEN THERAPEUTICS INC	3,150,000	$6.111M	3.3%	$1.94	—	COM NEW	92840H202
RLMD	RELMADA THERAPEUTICS INC	178,565	$5.727M	3.1%	$34.36	0.0%	COM	75955J402
SPRY	SILVERBACK THERAPEUTICS INC	97,143	$4.502M	2.4%	$33.40	0.0%	COM	82835W108
KURA	KURA ONCOLOGY INC	133,503	$4.36M	2.4%	$35.14	0.0%	COM	50127T109
—	SURFACE ONCOLOGY INC	467,796	$4.322M	2.3%	$9.24	—	COM	86877M209
GNCAQ	GENOCEA BIOSCIENCES INC	1,765,901	$4.273M	2.3%	$2.28	0.0%	COM NEW	372427401
—	MERSANA THERAPEUTICS INC	158,827	$4.226M	2.3%	$26.61	—	COM	59045L106
IMVT	IMMUNOVANT INC	83,782	$3.87M	2.1%	$46.23	0.0%	COM	45258J102
IVA	INVENTIVA SA	231,000	$3.35M	1.8%	$14.50	—	ADS	46124U107
—	BCLS ACQUISITION CORP	250,000	$2.785M	1.5%	$11.14	—	COM CL A	G0904B105
—	CYCLACEL PHARMACEUTICALS INC	264,690	$2.067M	1.1%	$7.81	—	COM	23254L603
—	MILLENDO THERAPEUTICS INC	925,000	$1.98M	1.1%	$2.14	—	COM	60040X103
—	LIFESCI ACQUISITION II CORP	100,000	$1.067M	0.6%	$10.67	—	COM	53229E103